IBN Announces Latest Episode of The Stock2Me Podcast featuring CEO Greg Campbell and CFO Jeff Clayborne of Newton Golf Company Inc.

(NASDAQ:NWTG), AUSTIN, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Stock2Me Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. […]

How Fenstermaker Uses Handheld Lidar to Map Schools for 911 Safety and Response

Huntsville, AL, Dec. 08, 2025 (GLOBE NEWSWIRE) — GeoCue announces the premiere of a new three-part edition of its award-winning reality series Down to Earth: Mapped Safe for 911. The latest episodes follow Fenstermaker, NEI, and the Lafayette Parish School System as they work with Lafayette Parish 911 to map every public and private school,

Westwood Holdings Group, Inc. Recognized in Pensions & Investments’ Best Places to Work in Money Management

(NYSE:WHG), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — Westwood Holdings Group, Inc. was recognized in the 2025 Best Places to Work in Money Management awards announced by Pensions & Investments today. Presented by Pensions & Investments, the global news source of money management and institutional investing, the 14th annual survey and recognition program is

Tessera Therapeutics Showcases New Preclinical Data Demonstrating Progress of In Vivo Programs for Sickle Cell Disease and T Cell Therapies at the 67th American Society of Hematology Annual Meeting

Presented new data in non-human primates (NHP) for sickle cell disease (SCD), where RNA Gene Writer achieved approximately 40% and 60% of long-term hematopoietic stem cells (LT-HSCs) with at least one edited allele after 1 or 2 doses, respectively, exceeding the anticipated curative threshold Evidence in NHP that T cell directed lipid nanoparticles (LNP) produced

RESTEM Announces First-Patient-Dosed in the Phase 1/2a Study of Restem-L in Facioscapulohumeral Muscular Dystrophy

âˆ' First patient with facioscapulohumeral muscular dystrophy (FSHD) dosed with Restem-L umbilical lining modified progenitor cells (UMPCs) âˆ' The Phase 1/2a study will evaluate the safety and preliminary efficacy of Restem-L in patients with FSHD âˆ' Clinical study is funded by SOLVE FSHD MIAMI and VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) — RESTEM

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Securities of Arrival SA and/or CIIG Merger Corp. – ARVLF

(PinkSheets:ARVLF), BROOKLYN, N.Y., Dec. 08, 2025 (GLOBE NEWSWIRE) — The Rosen Law Firm, P.A. announces that the United States District Court for the Eastern District of New York has approved the following announcement of a proposed class action settlement that would benefit purchasers of securities of Arrival SA and/or CIIG Merger Corp. (OTCMKTS: ARVLF): SUMMARY

ASML reports transactions under its current share buyback program

(Euronext Amsterdam:ASML),(NASDAQ:ASML), ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average price Total repurchased value 01-Dec-25 39,527 EUR915.08 EUR36,170,185 02-Dec-25 38,518 EUR939.05 EUR36,170,216 03-Dec-25 37,709 EUR959.19 EUR36,169,986 04-Dec-25 37,502 EUR964.47

Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron

Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron GlobeNewswire December 08, 2025 Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight loss up to

Rehab 4 Addiction CEO Releases New Article Sharing Effective Tips for Going Sober This December, And Actually Enjoying It

Rehab 4 Addiction CEO Releases New Article Sharing Effective Tips for Going Sober This December, And Actually Enjoying It GlobeNewswire December 08, 2025 London, England, Dec. 08, 2025 (GLOBE NEWSWIRE) — Rehab 4 Addiction, a leading treatment and alcohol home detox advisory service, is happy to announce the release of its new article, “The Most

Wicked Reserve Dispensary Expands Range with New Refrigerated THC Beverage Section

Wicked Reserve Dispensary Expands Range with New Refrigerated THC Beverage Section GlobeNewswire December 08, 2025 Rochester, NY, Dec. 08, 2025 (GLOBE NEWSWIRE) — Wicked Reserve Dispensary, a premier cannabis dispensary that has recently opened its doors in downtown Rochester, New York, is excited to announce that it has expanded its range with a new refrigerated

Scroll to Top